ライフサイエンスコーパス: deferral

1 or more of intensive treatment or treatment deferral).

2 those that are indolent (allowing treatment deferral).

3 68) resumed injections within 16 weeks after deferral.

4 tely after 3 weeks of treatment or treatment deferral.

5 symptoms of infection that would have led to deferral.

6 ed iron deficiency and avoid low haemoglobin deferrals.

7 2), but not from baseline to after treatment deferral (-0.03 points [4.04]; -0.94 to 0.88; between-gr

8 ation rates include increased rates of donor deferral and ineligibility; increased barriers to donati

9 c health measures that rely largely on donor deferral and sourcing of blood from non-outbreak areas u

10 ring the COVID-19 pandemic led to widespread deferrals and cancellations, creating a surgical backlog

11 resulted in more donation-related symptoms, deferrals, and iron deficiency.

12 ockdowns, government regulations and patient deferrals, and the secondary economic impacts of the pan

13 haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin and other factors.

14 haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin.

15 unction, especially when considered with CNI deferral beyond 10 d or lower target tacrolimus levels,

16 allocated immediate CEA versus all allocated deferral, but excluding such perioperative events, the 5

17 s qualified or unqualified using Dutch donor deferral criteria.

18 Source selection (e.g. country of origin, deferral for CJD risk factors) currently occupies the fr

19 More frequent donation resulted in more deferrals for low haemoglobin (odds ratio per week short

20 globin and ferritin concentrations, and more deferrals for low haemoglobin (p<0.0001 for each) than t

21 interval, 0.4-5.4 letters; P = 0.02) in the deferral group compared with the prompt laser treatment

22 In the deferral group, 54% did not receive laser treatment duri

23 In the prompt laser treatment group and deferral group, respectively, the percentage of eyes wit

24 njections was 13 versus 17 in the prompt and deferral groups, including 54% and 45% receiving no inje

25 injections were 12 and 15 in the prompt and deferral groups, respectively (P = 0.007), including 1 a

26 For the deferral groups, the index visit was a randomly selected

27 s), medium deferral (>=45 s to <120 s), long deferral (>=120 s), and intact cord milking.

28 were grouped into immediate clamping, short deferral (>=15 s to <45 s), medium deferral (>=45 s to <

29 ng, short deferral (>=15 s to <45 s), medium deferral (>=45 s to <120 s), long deferral (>=120 s), an

30 erapy strategies, postoperative radiotherapy deferral has gained acceptance in children younger than

31 th poorer OS were postoperative radiotherapy deferral (hazards ratio [HR], 1.95; 95% CI, 1.15-3.31);

32 ncreasing rate of postoperative radiotherapy deferral in children with medulloblastoma ages 3 to 8 ye

33 the use of induction rATG and concurrent CNI deferral in this study did not demonstrate a significant

34 sis suggests that postoperative radiotherapy deferral is associated with worse survival in this age g

35 Thus, deferral is controlled by a pulsed positive feedback loo

36 ily values regarding nondisclosure, but such deferral is not unique to cultural differences.

37 local therapy should not be deferred unless deferral is specifically recommended in this guideline.

38 by angiography, including revascularization deferral, is safe in ACS.

39 delay 1 month, IQR 0.3-2.5) or to indefinite deferral of any carotid procedure, and were followed up

40 llocated immediate CEA versus 1560 allocated deferral of any carotid procedure.

41 EA by 1 month, 88% by 1 year) and indefinite deferral of any CEA (only 4% per year got CEA) and were

42 ous Medicaid enrollment, continuity of care, deferral of care, and number of visits.

43 he availability of the perfusion data led to deferral of catheterization in 48 cases (46.6%).

44 This study found that long deferral of clamping leads to reduced odds of death befo

45 Stenting allowed deferral of complete surgical repair to an age (6 months

46 m baseline to follow-up examination, despite deferral of coronary intervention in all patients.

47 The deferral of events in mammalian embryogenesis might be d

48 w risk of decompensations in the short term; deferral of HCV therapy for a few years and monitoring f

49 nguage therapy (>/=10 h per week) or 3 weeks deferral of intensive speech and language therapy.

50 rformed in 130 patients (64%) and led to the deferral of LPs in 7 (5%).

51 nce that recommended a change in blood donor deferral of men who have sex with men (MSM) from an inde

52 Deferral of men who have sex with men (MSM) from blood d

53 This study is clinically relevant because deferral of on time implantation leads to spontaneous pr

54 trated that the use of upfront EGFR-TKI, and deferral of radiotherapy, is associated with inferior OS

55 Deferral of revascularization based on iFR appears to be

56 cutaneous coronary intervention (PCI) versus deferral of revascularization in patients with intermedi

57 Deferral of revascularization was associated with a high

58 ographically indeterminate LMCA lesions, and deferral of revascularization was recommended when the M

59 Despite fractional flow reserve (FFR)-guided deferral of revascularization, recurrent events in patie

60 o conflicting data on the performance versus deferral of revascularization.

61 ard strategy of the STARRT-AKI trial, longer deferral of RRT initiation was not associated with a hig

62 g the sporulation kinases, without which the deferral of sporulation became ultrasensitive to kinase

63 The deferral of surgery in the minority of patients who prog

64 ce at the outset of the COVID-19 pandemic on deferral of surgical and perioperative interventions, bu

65 Sequential radiotherapy might facilitate deferral of systemic therapy initiation and could allow

66 Guidelines recommend deferral of testing for symptomatic people with suspecte

67 Episodic use involved the deferral of therapy until the CD4+ count decreased to le

68 ned by whether the patient will be harmed by deferral of therapy.

69 At the lesion level, deferral of those with an FFR</=0.80 was associated with

70 a, suggesting that antenatal chemotherapy or deferral of treatment until postpartum in selected patie

71 isits, greater continuity of care, and fewer deferrals of care.

72 d adverse events during therapy or treatment deferral (one car accident [in the control group], two c

73 targeted social safety net programs, payment deferrals, or tax breaks as well as suitable cash-suppor

74 abine (200 mg) either immediately or after a deferral period of 1 year.

75 s included incident HIV infection during the deferral period, safety, adherence, and risk compensatio

76 risk after implementation of a 12-month MSM deferral policy.

77 ars after implementation of the 12-month MSM deferral policy.

78 Of all interventions, long deferral reduced death before discharge the most (compar

79 s of gestation), but the optimal duration of deferral remains unclear.

80 interventions since 1970, particularly donor deferral, screening for hepatitis B and human immunodefi

81 h men (MSM) from an indefinite to a 12-month deferral since the donor last had sex with a man.

82 Learning, CoRaX, Perceptual Error, Referral, Deferral Supplemental material is available for this art

83 How can cells set a deferral time much longer than the cell cycle?

84 provides a more robust mechanism for setting deferral times than constitutive kinase expression.

85 back can enable more accurate tuning of long deferral times.

86 re 2.68 (p = 0.003) and 1.05 (p = 0.897) for deferral to <200 cells/microl and 200-349 cells/ micro l

87 on between July 1995 and January 2000: <200 (deferral to <200, n = 127), 200-349 (deferral to 200-349

88 : <200 (deferral to <200, n = 127), 200-349 (deferral to 200-349, n = 130), and 350-499 (immediate tr

89 We developed Complementarity-Driven Deferral to Clinical Workflow (CoDoC), a system that can

90 Moreover, FFR-based deferral to medical treatment was as safe in patients wi

91 allow for postponement of elective cases and deferral to nonsurgical modalities of stage II/III recta

92 fe years [LYs]) and decreased with treatment deferral until 6 years old (76.10 LYs), 12 years old (75

93 re costs and increase survival compared with deferral until age 6 years or older.

94 0 cells per muL assigned to immediate ART or deferral until their CD4 cell counts were lower than 350

95 0.22-2.79]; P=0.71, I2=65%) was similar with deferral versus performance of revascularization in coro

96 rs before implementation of the 12-month MSM deferral was estimated at 2.62 cases per 100 000 person-

97 s associated with postoperative radiotherapy deferral were age (odds ratio [OR], 0.57 per year; 95% C

98 s associated with postoperative radiotherapy deferral were identified using multivariable logistic re

99 mpliance with allocation to immediate CEA or deferral would, in expectation, have produced slightly b